Cytogenetic remission status after induction chemotherapy for AML and high-risk MDS predicts long-term outcome.

被引：0
|
作者：
Sebastian, B
Hildebrand, B
Royer-Prokora, B
Kuendgen, A
Gattermann, N
Germing, U
Haas, R
机构：
[1] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3009
引用
收藏
页码：822A / 822A
页数：1
相关论文
共 50 条
  • [1] Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS
    Joshua F. Zeidner
    Hanna A. Knaus
    Amer M. Zeidan
    Amanda L. Blackford
    Raul Montiel-Esparza
    Hubert Hackl
    Gabrielle T. Prince
    Lukasz P. Gondek
    Gabriel Ghiaur
    Margaret M. Showel
    Amy E. DeZern
    Keith W. Pratz
    B. Douglas Smith
    Mark J. Levis
    Steven Gore
    Catherine C. Coombs
    Matthew C. Foster
    Howard Streicher
    Judith E. Karp
    Leo Luznik
    Ivana Gojo
    [J]. Leukemia, 2020, 34 : 1563 - 1576
  • [2] Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS
    Zeidner, Joshua F.
    Knaus, Hanna A.
    Zeidan, Amer M.
    Blackford, Amanda L.
    Montiel-Esparza, Raul
    Hackl, Hubert
    Prince, Gabrielle T.
    Gondek, Lukasz P.
    Ghiaur, Gabriel
    Showel, Margaret M.
    DeZern, Amy E.
    Pratz, Keith W.
    Smith, B. Douglas
    Levis, Mark J.
    Gore, Steven
    Coombs, Catherine C.
    Foster, Matthew C.
    Streicher, Howard
    Karp, Judith E.
    Luznik, Leo
    Gojo, Ivana
    [J]. LEUKEMIA, 2020, 34 (06) : 1563 - 1576
  • [3] Tandem high-dose chemotherapy versus dose-dense conventional chemotherapy in high-risk breast cancer: predictors of long-term outcome.
    Nitz, U
    Gluz, O
    Mohrmann, S
    Werner, F
    Brandt, M
    Poremba, C
    Diallo, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S102 - S102
  • [4] Long-term outcome after successful MitraClip implantation in high-risk patients
    Lubos, Edith
    Tigges, Eike
    Kalbacher, Daniel
    Thomas, Christina
    Deuschl, Florian
    Schofer, Niklas
    Conradi, Lenard
    Schirmer, Johannes
    Schaefer, Ulrich
    Reichenspurner, Hermann
    Blankenberg, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B224 - B224
  • [5] Randomized study comparing chemotherapy ±GM-CSF in high-risk MDS and AML following MDS (MDS-AML).
    Ohm, AC
    Hast, R
    Bernell, P
    Celsing, F
    Dahl, IM
    Dybedal, I
    Lindberg, G
    Linder, O
    Löfvenberg, E
    Nilsson-Ehle, H
    Samuelsson, J
    Tangen, J
    Turesson, I
    Wallvik, J
    Winquist, I
    Öberg, G
    Björkholm, M
    Hellström-Lindberg, E
    [J]. BLOOD, 2000, 96 (11) : 148A - 148A
  • [6] Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
    Grovdal, Michael
    Karimi, Mohsen
    Khan, Rasheed
    Aggerholm, Anni
    Antunovic, Petar
    Astermark, Jan
    Bernell, Per
    Engstrom, Lena-Maria
    Kjeldsen, Lars
    Linder, Olle
    Nilsson, Lars
    Olsson, Anna
    Holm, Mette S.
    Tangen, Jon M.
    Wallvik, Jonas
    Oberg, Gunnar
    Hokland, Peter
    Jacobsen, Sten E.
    Porwit, Anna
    Hellstrom-Lindberg, Eva
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (03) : 293 - 302
  • [7] Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML
    Bjorklund, Andreas T.
    Carlsten, Mattias
    Sohlberg, Ebba
    Clancy, Trevor
    Liu, Lisa
    Karimi, Mohsen
    Cooley, Sarah
    Miller, Jeffrey S.
    Watz, Emma
    Wahlin, Bjorn Engelbrekt
    Palma, Marzia
    Hansson, Lotta
    Ljungman, Per
    Hellstrom-Lindberg, Eva
    Ljunggren, Hans-Gustaf
    Malmberg, Karl-Johan
    [J]. BLOOD, 2017, 130
  • [8] Ultrasound remission after biologic induction predicts long-term endoscopic remission in Crohn's disease
    Allocca, M.
    Dell'Avalle, C.
    Furfaro, F.
    Zilli, A.
    Radice, S.
    D'Amico, F.
    Peyrin-Biroulet, L.
    Fiorino, G.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 468 - 468
  • [9] ULTRASOUND REMISSION AFTER BIOLOGIC INDUCTION PREDICTS LONG-TERM ENDOSCOPIC REMISSION IN CROHN'S DISEASE
    Allocca, M.
    Dell'Avalle, C.
    Furfaro, F.
    Zilli, A.
    Radice, S.
    D'Amico, F.
    Peyrin-Biroulet, L.
    Fiorino, G.
    Danese, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S94 - S94
  • [10] ULTRASOUND REMISSION AFTER BIOLOGIC INDUCTION PREDICTS LONG-TERM ENDOSCOPIC REMISSION IN CROHN'S DISEASE
    Allocca, Mariangela
    Dell'Avalle, Cecilia
    Federica, Furfaro
    Zilli, Alessandra
    Simona, Radice
    D'Amico, Ferdinando
    Peyrin-Biroulet, Laurent
    Gionata, Fiorino
    Silvio, Danese
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S665 - S665
12345